Ocular Therapeutix
(NASDAQ) OCUL
Ocular Therapeutix Financials at a Glance
Market Cap
$2.11B
Revenue (TTM)
$52.04M
Net Income (TTM)
-$290.50M
EPS (TTM)
-$1.46
P/E Ratio
-6.62
Dividend
$0.00
Beta (Volatility)
1.50 (Average)
Dividend
$0.00
Beta (Volatility)
1.50 (Average)
Price
$9.45
Volume
197,096
Open
$9.97
Price
$9.45
Volume
197,096
Open
$9.97
Previous Close
$9.45
Daily Range
$9.38 - $10.34
52-Week Range
$6.23 - $16.44
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.50 (Average)
Price
$9.45
Volume
197,096
Open
$9.97
Previous Close
$9.45
Daily Range
$9.38 - $10.34
52-Week Range
$6.23 - $16.44
Estimated Earnings Date
Aug 5, 2026
OCUL News
OCUL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ocular Therapeutix
Industry
Pharmaceuticals
Sector
Health CareEmployees
325
CEO
Pravin U. Dugel, MD
Website
www.ocutx.comHeadquarters
Bedford, MA 01730, US
OCUL Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-69%
Return on Capital
-44%
Return on Assets
-40%
Earnings Yield
-15.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.11B
Shares Outstanding
218.96M
Volume
197.10K
Avg. Volume
3.06M
Financials (TTM)
Gross Profit
$45.25M
Operating Income
-$270.02M
EBITDA
-$249.78M
Operating Cash Flow
-$204.88M
Capital Expenditure
-$12.01M
Free Cash Flow
-$216.89M
Cash & ST Invst.
$737.06M
Total Debt
$79.78M
Ocular Therapeutix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.79M
+0.8%
Gross Profit
$9.46M
+0.2%
Gross Margin
87.68%
N/A
Market Cap
$2.11B
N/A
Market Cap/Employee
$7.70M
N/A
Employees
274
N/A
Net Income
-$88.61M
-38.3%
EBITDA
-$84.55M
-40.7%
Quarterly Fundamentals
Total Cash
$666.70M
+90.7%
Total Debt
$79.46M
+4.2%
Accounts Receivable
$24.35M
-3.5%
Inventory
$3.74M
+14.3%
Long Term Debt
$76.29M
+3.0%
Short Term Debt
$3.17M
+47.0%
Return on Assets
-39.66%
N/A
Return on Invested Capital
-43.72%
N/A
Free Cash Flow
-$70.66M
-51.6%
Operating Cash Flow
-$65.99M
-47.7%